What companies are FATE's competitors?

Fate Therapeutics, Inc. (FATE)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.

How does FATE compare to its peers?

The peer comparison table on this page shows Fate Therapeutics, Inc. (FATE) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.

What sector does FATE operate in?

Fate Therapeutics, Inc. (FATE) operates in the Biotechnology industry within the Healthcare sector. Peers are drawn from this classification — companies with similar revenue mix, cost structure, and customer demand drivers.

FATE

Fate Therapeutics, Inc.

NASDAQ·Biotechnology · Healthcare

$2.33$0.12−4.90%

Pre-market·$2.33−0.21%

Market cap$271.58M·Market closed·Aug 21 8:00 PM UTC

Frequently Asked Questions About FATE

What companies are FATE's competitors?: Fate Therapeutics, Inc. (FATE)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.
How does FATE compare to its peers?: The peer comparison table on this page shows Fate Therapeutics, Inc. (FATE) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.
What sector does FATE operate in?: Fate Therapeutics, Inc. (FATE) operates in the Biotechnology industry within the Healthcare sector. Peers are drawn from this classification — companies with similar revenue mix, cost structure, and customer demand drivers.

FATE

Fate Therapeutics, Inc.

NASDAQ·Biotechnology · Healthcare

$2.33$0.12−4.90%

Pre-market·$2.33−0.21%

Market cap$271.58M·Market closed·Aug 21 8:00 PM UTC

Peers


VOR	Vor Biopharma Inc.	$23.36	$1.3B
PRLD	Prelude Therapeutics Incorporated	$6.63	$377.5M
ALEC	Alector, Inc.	$2.36	$262.0M
ABOS	Acumen Pharmaceuticals, Inc.	$3.16	$228.2M
PEPG	PepGen Inc.	$3.14	$217.2M
CRBP	Corbus Pharmaceuticals Holdings, Inc.	$10.38	$192.3M
NKTX	Nkarta, Inc.	$2.66	$190.3M
MOLN	Molecular Partners AG	$4.40	$165.0M
INO	Inovio Pharmaceuticals, Inc.	$1.18	$81.5M
SAVA	Cassava Sciences, Inc.	$1.32	$63.8M

Frequently Asked Questions About FATE

What companies are FATE's competitors?: Fate Therapeutics, Inc. (FATE)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.
How does FATE compare to its peers?: The peer comparison table on this page shows Fate Therapeutics, Inc. (FATE) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.
What sector does FATE operate in?: Fate Therapeutics, Inc. (FATE) operates in the Biotechnology industry within the Healthcare sector. Peers are drawn from this classification — companies with similar revenue mix, cost structure, and customer demand drivers.